Catequentinib/ceritinib/crizotinibDrug resistance and lack of efficacy : case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-30519-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：378 / 378

相关论文

共 50 条

[21] Catequentinib/rivoceranibRash and lack of efficacy: 3 case reports [J].

Reactions Weekly, 2023, 1961 (1) :119-119

[22] Catequentinib/gefitinibLack of efficacy: case report [J].

Reactions Weekly, 2022, 1934 (1) :123-123

[23] Catequentinib/paclitaxelLack of efficacy: case report [J].

Reactions Weekly, 2025, 2060 (1) :93-93

[24] Catequentinib/osimertinibLack of efficacy: case report [J].

Reactions Weekly, 2023, 1946 (1) :150-150

[25] Catequentinib/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2021, 1869 (1) :93-93

[26] Catequentinib/osimertinibLack of efficacy: case report [J].

Reactions Weekly, 2023, 1970 (1) :88-88

[27] Catequentinib/nivolumabLack of efficacy: case report [J].

Reactions Weekly, 2023, 1977 (1) :92-92

[28] Catequentinib/IrinotecanLack of efficacy: case report [J].

Reactions Weekly, 2025, 2073 (1) :97-97

[29] Catequentinib/HeparinPulmonary-embolism with deep vein thrombosis and lack of efficacy : case report [J].

Reactions Weekly, 2025, 2063 (1) :78-78

[30] Catequentinib/pemetrexed/savolitinibHaemoptysis, lack of efficacy and off-label use: case report [J].

Reactions Weekly, 2025, 2063 (1) :79-79

← 1 2 3 4 5 →